2011 Annual Meeting | Update in Neuroimaging: Essentials and BeyondPart II

Date Monday 04/11/11

Time 09:00 AM - 01:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Eric C. Lindzen, MD, PhD

Topic(s)

Learning Objectives Participants should be able to develop a neuroimaging checklist that will improve their diagnostic accuracy when interpreting or reviewing neuroimaging studies; have an improved ability to integrate their clinical and imaging skills towards identifying significant findings whose recognition positively impacts patient management; define major categories of lesions and other abnormalities detectable on MRI and CT examinations of the brain and spine in clinical practice; be familiar with newer imaging techniques and their relevance to patient care in both the hospital and outpatient settings; and understand the physical basis of conventional MRI techniques, including basic MRI pulse sequence design concepts with specific application to various central nervous system disorders, including multiple sclerosis, dementia, stroke, hemorrhage, and brain tumors.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic

Event Timeline
09:00 AM - 09:50 AM		MRI and CT of Intracranial Hemorrhage Eric C. Lindzen, MD, PhD
09:50 AM - 10:40 AM		MRI of Basal Ganglia Pathology Mohammed J. Zafar, MD, FAAN
10:40 AM - 10:55 AM		Break
10:55 AM - 11:45 AM		Incidental Findings on MRI of the Brain and Spine Bela Ajtai, MD
11:45 AM - 12:35 PM		Spine Tumors Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN
12:35 PM - 01:00 PM		Questions and Answers

Faculty Disclosures
Eric C. Lindzen, MD, PhD	No disclosure on file
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN	Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharma. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Genomate Health. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Alpheus medical. The institution of Dr. Mechtler has received research support from Shiratronics. The institution of Dr. Mechtler has received research support from Abbvie Inc. The institution of Dr. Mechtler has received research support from Amgen. The institution of Dr. Mechtler has received research support from Eli Lilly Company. The institution of Dr. Mechtler has received research support from H. Lundbeck HS. The institution of Dr. Mechtler has received research support from Pfizer. Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Ownership interest with Neurology Practce Consortium GPO. Dr. Mechtler has a non-compensated relationship as a Board member with International Headache Society that is relevant to AAN interests or activities.
Mohammed J. Zafar, MD, FAAN	No disclosure on file
Bela Ajtai, MD	Dr. Ajtai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.

��ɫ��

��ɫ��